You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 22, 2025

Drug Price Trends for NDC 49348-0133


✉ Email this page to a colleague

« Back to Dashboard


Average Pharmacy Cost for 49348-0133

Drug Name NDC Price/Unit ($) Unit Date
SM IODINE 2% TINCTURE 49348-0133-27 0.06820 ML 2025-03-19
SM IODINE 2% TINCTURE 49348-0133-27 0.06791 ML 2025-02-19
SM IODINE 2% TINCTURE 49348-0133-27 0.06830 ML 2025-01-22
SM IODINE 2% TINCTURE 49348-0133-27 0.06852 ML 2024-12-18
SM IODINE 2% TINCTURE 49348-0133-27 0.06907 ML 2024-11-20
SM IODINE 2% TINCTURE 49348-0133-27 0.06800 ML 2024-10-23
SM IODINE 2% TINCTURE 49348-0133-27 0.06845 ML 2024-09-18
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for NDC 49348-0133

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Market Analysis and Price Projections for Drug NDC: 49348-0133

Understanding NDC Codes

To begin with, it's crucial to understand what an NDC (National Drug Code) is. The NDC is a unique 11-digit code assigned to each drug product, including prescription and over-the-counter drugs, by the FDA. This code helps in identifying the drug, its strength, and the labeler (manufacturer, repackager, or relabeler)[5].

Identifying the Drug

The NDC code 49348-0133 is not explicitly mentioned in the provided sources, so we need to look up the specific drug associated with this code. Generally, this involves checking the FDA's National Drug Code Directory or other pharmaceutical databases.

Pharmaceutical Market Trends

General Market Outlook

The pharmaceutical market is experiencing several key trends that influence drug pricing and availability. Here are some critical points:

  • Specialty Pharmaceuticals: These drugs, which treat complex or chronic conditions such as cancer, infectious diseases, autoimmune diseases, and pulmonary conditions, are driving a significant portion of the price increases. Vizient projects a 3.8% increase in drug prices, largely driven by specialty pharmaceuticals[4].
  • Gene Therapies: The anticipated expansion of gene therapies is expected to further increase provider spend on pharmaceuticals[4].
  • Biosimilars: While biosimilars are gaining market share, they are expected to increase in price by only 0.55%, which is relatively low compared to other segments[4].

Policy and Regulatory Changes

The pharmaceutical industry is also subject to policy and regulatory changes that can impact drug pricing and availability. For instance, changes in government policies, tariffs, taxes, and M&A oversight can significantly influence the market[3].

Pricing Dynamics

Current Pricing

To determine the current price of the drug associated with NDC 49348-0133, one would typically refer to pricing lists provided by state Medicaid programs, pharmacy benefit managers, or other healthcare organizations. For example, the Missouri Specialty MAC list provides detailed pricing information for various drugs effective January 1, 2023[2].

Projected Price Increases

Given the overall trend of a 3.8% increase in drug prices, it is likely that the price of the drug associated with NDC 49348-0133 will also see an increase. However, the exact percentage increase would depend on whether the drug falls under the category of specialty pharmaceuticals or another segment.

Impact of Unapproved Drugs

It is important to note that some drugs may be deemed unapproved by the FDA, which can affect their pricing and availability. For instance, drugs without approved New Drug Applications (NDAs) cannot be marketed without FDA approval and are not eligible for inclusion in rebate programs[1].

Personalization and Prevention

The future of the pharmaceutical industry is moving towards more personalized and preventive care. This includes data-driven, customized treatments based on genetics and behavior, and early intervention to improve health outcomes. While this trend does not directly impact the pricing of a specific drug, it indicates a broader shift in how healthcare is delivered and could influence long-term pricing strategies[3].

Key Takeaways

  • Market Trends: The pharmaceutical market is driven by increases in specialty pharmaceuticals and gene therapies.
  • Pricing Projections: A general 3.8% increase in drug prices is projected, with specialty pharmaceuticals seeing a higher increase.
  • Regulatory Impact: FDA approvals and regulatory changes can significantly affect the pricing and availability of drugs.
  • Personalization: The industry is moving towards more personalized and preventive care, which could influence future pricing strategies.

FAQs

Q: What is the significance of the NDC code in the pharmaceutical industry? A: The NDC code is a unique identifier for each drug product, helping in identifying the drug, its strength, and the labeler.

Q: How are drug prices projected to change in 2024? A: Drug prices are projected to increase by 3.8%, driven largely by specialty pharmaceuticals and the expansion of gene therapies.

Q: What role do biosimilars play in the pharmaceutical market? A: Biosimilars are expected to gain market share, especially as pharmacy benefit managers finalize their formulary strategies, but they are projected to increase in price by only 0.55%.

Q: How do regulatory changes impact drug pricing? A: Regulatory changes, such as FDA approvals and policy changes, can significantly affect the pricing and availability of drugs by determining which drugs are eligible for rebate programs and commercial distribution.

Q: What are the key trends shaping the future of the pharmaceutical industry? A: The key trends include a focus on prevention, personalization, prediction, and point of care, along with significant policy and regulatory changes.

Sources

  1. Medicaid.gov: For State Medicaid Directors - NEW DRUG DETERMINATIONS--DELETIONS FROM MDR
  2. Missouri Department of Social Services: MISSOURI SPECIALTY MAC NAME OF DRUG Strength NDC Price Effective January 1, 2023
  3. PwC: Pharma industry trends: Meeting the moment - Five transformative trends shaping 2025 and beyond
  4. Vizient Inc.: Vizient Projects 3.8% Drug Price Increase Driven by Specialty Pharmaceuticals
  5. FDA: National Drug Code Directory - FDA

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.